The Government of Canada has announced its intention to merge BDC and EDC. Today, BDC remains BDC, and we remain fully committed to Canadian entrepreneurs. To learn more, click here.

The Government of Canada has announced its intention to merge BDC and EDC. Today, BDC remains BDC, and we remain fully committed to Canadian entrepreneurs. To learn more, click here.
FR
Search
Search
Vida Therapeutics Inc. logo
Portfolio company

Vida Therapeutics Inc.

Details
Region
Prairies and West
Industry sector
Biotechnology
Investment year
2012
Fund
Diversified Portfolio
Learn more
About the company

viDA Therapeutics is advancing first-in-class drugs based on inhibitors of the extracellular serine protease, Granzyme B, to treat autoimmune and chronic inflammatory diseases. The company is focused on advancing their lead candidate into the clinic.